SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AVAH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
March 31, 2026 129.95M
December 31, 2025 136.92M
September 30, 2025 147.40M
June 30, 2025 124.60M
March 31, 2025 128.89M
December 31, 2024 122.16M
September 30, 2024 120.08M
June 30, 2024 118.22M
March 31, 2024 117.76M
December 31, 2023 115.31M
September 30, 2023 118.45M
Date Value
June 30, 2023 117.61M
March 31, 2023 122.64M
December 31, 2022 121.83M
September 30, 2022 122.76M
June 30, 2022 125.20M
March 31, 2022 125.31M
December 31, 2021 106.63M
September 30, 2021 114.24M
June 30, 2021 110.12M
March 31, 2021 96.77M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
The Pennant Group, Inc. 19.69M
Addus HomeCare Corp. 77.77M
Viemed Healthcare, Inc. 37.24M
Option Care Health, Inc. 174.56M
Chemed Corp. 114.32M